The immunosuppressive potency of antilymphocyte serum is related to activity against human thymic lymphocyte-specific antigens.
D000818:Animals; D000918:Antibody Specificity; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D001402:B-Lymphocytes / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D000882:Haplorhini; D006382:Hemadsorption; D006801:Humans; D007165:Immunosuppression Therapy; D008251:Macaca; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000276:immunology*; D014181:Transplantation Immunology; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum